Latest Content From Ruairi J MacKenzie
The value of information to many companies across the biomedical area is incalculable, but there has been a reluctance to embrace the need to properly store that data to maxmize its utility. We talked to Arawan Gajajiva, a principal solution architect at cloud data warehouse provider Matillion, to find out that can be changed.
Releasing the Handbrake on Endogenous Repair – An Alternative Approach to Treating Alzheimer’s Disease?Blog
Technology Networks recently spoke with Paul Brennan, President and CEO at NervGen Pharma, to gain his insights on why previous attempts to treat Alzheimer's disease have failed, how the novel technology platform NVG-291 works and what promise it holds for AD.VIEW
In this interview we speak to Maastricht University's Professor Johannes Ramaekers, who recently collaborated with the UK-based Beckley foundation to examine the effects of microdosing LSD. In this interview, we discuss how LSD affects our mood, how mushrooms could boost creativity and and why a Mexican toad has been an important part of psychedelic research.
Fred Barrett is an Assistant Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University in Baltimore. In this interview, we discuss his work with the active component of magic mushrooms, psilocybin. Fred explains how this compound affects the brain, its potential to combat visceral pain, and its links to so-called mystical experiences.
2019 has been an important year for neuroscience research. In this list, we look at 10 of the most important stories in neuroscience from the last year, touching on brain implants, adult neurogenesis and promising therapies for neurological conditions. Here's to another huge new year (and decade) in 2020!
A new study conducted by researchers at Paris’s Sorbonne University, alongside colleagues from the US and Australia has now suggested that magnetic stimulation may be able to help the brain repair itself. What’s more, the team has gone one step further by identifying a molecule that they suggest may mediate this healing effect.VIEW
Professor David Nutt has never been afraid to stick his head above the parapet on the topic of drugs. His repeated calling-out of the failures of contemporary drug policy has seen him butt heads with academics and politicians alike. In this interview with Professor Nutt, we discuss pot, policy and the potential of psilocybin.VIEW
In this article, we revisit the many twists and turns of the aducanumab clinical trials and explore the scientific community's response to the latest analysis of the data.VIEW
In our latest interview series, we discuss the potential of psychedelics to revolutionize clinical neuroscience with thought leaders in the field. In this first interview of our series exploring the Neuroscience of Psychedelics, we talk to Johns Hopkins Associate Professor Gul Dölen, who has spent years exploring the effects of MDMA on the mammalian (and more recently, cephalopod) brain.
Neuroscience 2019, the world’s biggest conference of brain science, finished just over a month ago. In the wake of some particularly inflammatory headlines, we take a closer look at whether claims that new model systems for studying the brain could produce sentience in a jar have any truth to them.